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Abstract 
Background: The Caudal-related homeobox transcription factor 2 (CDX2) is expressed in the 
intestinal epithelium where it controls cell differentiation and homeostasis. Previous studies suspect 
CDX2 to have a variant named vCDX2 expressed from a CUG start codon. vCDX2 is suspected to 
have a dominant negative effect on CDX2 causing a change in the function of the epithelial cells of 
the intestine as lack of CDX2 will affect the differentiation of the cells. 
Aim: This project investigates whether vCDX2 translation is initiated from a CUG codon or an up- 
or downstream translation initiation site. 
Methods: Site-directed mutagenesis was performed by use of two primer sets. Three different 
FLAG-tagged plasmids (UUUvCDX2, CUGvCDX2 and UAGvCDX2) were used to examine whether 
vCDX2 translation is initiated from a CUG codon or from an up- or downstream translation 
initiation site. A Western Blot was performed to identify synthesized vCDX2 protein. 
Results: No vCDX2 protein was visualized on the blot.  
Conclusion: No FLAG-tagged vCDX2 protein was visualized. Consequently we cannot conclude if 
the translation of vCDX2 is initiated from a CUG codon or an up- or downstream translation 
initiation site. 
 
Resumé 
Baggrund: Den Caudal-related homeobox transkriptions faktor 2 (CDX2) er udtrykt i tarmepitelet, 
hvor den kontrollerer celledifferentiering og homostase. Tidligere studier har indikeret at CDX2 har 
en isoform kaldet vCDX2 som er udtrykt fra et CUG start codon. Det er mistænkt at vCDX2 har en 
dominant negativ effekt på CDX2, der medfører en ændring i epitelcellernes funktion, da mangel på 
CDX2 vil påvirke celledifferentieringen.  
Formål: Dette projekt undersøger om translation af CDX2 bliver initieret fra et CUG codon eller et 
up-eller downstream translations initierings site.  
Metode: Site-directed mutagenisis blev udført ved brug af to primer sæt. Tre forskellige FLAG-
taggede plasmider (UUUvCDX2, CUGvCDX2 and UAGvCDX2) blev brugt til at undersøge om 
translation af vCDX2 bliver initieret fra et CUG codon eller fra et up- eller downstream translations 
initierings site. For at identificere syntetiseret vCDX2 protein blev der lavet et Western Blot.  
Resultater: Intet vCDX2 protein blev visualiseret på blottet.  
Konklusion: Der blev ikke visualiseret noget FLAG-tagged vCDX2 protein. Derfor kan vi ikke 
konkludere om translationen af vCDX2 er initieret fra et CUG codon eller et up- eller downstream 
translations initierings site.  
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Introduction 
Proteins are polypeptides essential for all life. Their functions are diverse and multiple ranging from 
being enzymes, to molecule transporters, to antibodies, to hormones etc. Each synthesize of a 
protein starts with the transcription of a gene specific for the protein. From the transcription start 
until the protein is able to perform its function, it undergoes different posttranslational 
modifications: From its primary structure until it reaches its quaternary structure (Rewieved in 
Griffiths et al. 2012). 
Transcription 
Transcription is the process of transcribing mRNA from a DNA template. Transcription initiation is 
started in a region of the DNA strand called the transcription start site. When transcription is to 
begin an σ subunit of the RNA polymerase recognizes special regions in the promoter. Promoters 
are located upstream of the transcription start site where a sequence called a TATA box is located 
(Reviewed in Griffiths et al. 2012).  
The TATA-binding protein (TBP) binds to the TATA box, as the first event in transcription.  
TBP is a part of the Transcription factor TFIID. TFIID is one of six different general transcription 
factors involved in the transcription initiation. Once the TBP is bound to the TATA box, other 
GTFs and the RNA Polymerase II is attracted, forming the Pre initiation complex (PIC). When the 
PIC is formed the transcription can begin (Rewieved in Griffiths et al. 2012).   
 
When transcription has begun RNA polymerase II and GTFs let go of each other. The σ subunit in 
the RNA polymerase II, departs and the RNA polymerase II continuously synthesizes RNA by 
pairing ribonucleotides with its complementary nucleotides in the DNA template. During elongation 
the RNA polymerase inserts a uracil when it encounters an adenine, an adenine when it encounters 
thymine and cytosine and guanine is paired with each other (Reviewed in Griffiths et al., 2012). The 
mRNA for the specific protein is then translated till the proteins primary structure, a polypeptide 
(Rewieved in Griffiths et al. 2012). 
RNA is always synthesized in the 5’-to-3’ direction and thus nucleotides are added at the 3’ end. 
This means that the orientation of the template strand is 3’ to 5’ (Reviewed in Griffiths et al., 2012). 
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Translation initiation 
AUG codon 
The translation of mRNA into protein takes place on the endoplasmic reticulum in the cytoplasm. 
The ribosome consists of two major subunits 40S and 60S. Before the translation initiation, the 40S 
subunit is preloaded with eukaryote initiation factors eIF1, eIF3 and eIF1A. The tRNAi containing 
the anti-codon for AUG is preloaded with methionine and eIF2 which have guanosine triphosphate 
(GTP) bound to it. Together with eIF5 and eIF5B it forms a complex 43S (see figure 1) (Reviewed 
in Erickson and Hannig 1996; Schwab et al. 2004). 
 
 
Figure 1: Translation initiation. Figure copied  from Calkhoven, Müller, and Leutz 2002. 
 
The mRNA binds to eIF4F which mediates the binding of eIF4 and the 43S subunit creating a 48S 
subunit. This subunit is scanning the mRNA until the anti-codon on tRNAi reaches the AUG codon 
in a good Kozak sequence. The Kozak sequence is a certain order of nucleotides that increases the 
translation initiation. The Kozak sequence is as follows: (GCC)GCC𝐴𝐴𝐺𝐺CCAUGG. All the positions 
beside position -9, -6, -3 and +4 have a cytosine.  In position -3 a purine is the most common and 
out of adenine and guanine, adenine is the most abundent. Depending on the nucleotide in position -
3 and +4 the Kozak sequence can be either strong or weak. A strong Kozak sequence has to have a 
purine (guanine or adenine) in position -3 and a guanine at position +4. A strong Kozak sequence 
leads to a higher degree of translation initiation (Kozak 1987).  
If the sequence 12-15 nucleotides from the translation initiation codon are cytosine and guanine 
rich, it will increase the possibility of translation initiation for AUG in a weak Kozak sequence. 
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Furthermore Schwab et al. 2004 suspects that this also applies for CUG translation initiation 
codons. The increased possibility of translation initiation is due to the cytosine and guanine rich 
sequence forming a hairpin structure. The hairpin structure will slow down the ribosome and as a 
result the ribosome will have better time to recognize the translation initiation site (Kozak 1990; 
Schwab et al. 2004). 
When the tRNAi anti-codon reaches the AUG codon the subunits eIF5, eIF5B, eIF2, eIF1, eIF1A, 
eIF3 are released, and the remaining subunits form an initiation complex with the 60S subunit 
creating a 80S subunit complex (Reviewed in Erickson and Hannig 1996; Schwab et al. 2004).  
Alternative translation initiation sites 
Far the most translations of mRNA are initiated from an AUG codon, but some proteins are 
initiated from an alternative start codon. Alternative translation initiation was first discovered in 
1988 in virus, and since multiple alternative translation initiation codons have been discovered. 
Among the genes containing alternative translation initiation codons, a great number synthesize 
proteins with regulatory functions such as transcription factors, proto-oncogenes, kinases and 
growth factors.  Alternative translation initiation may cause one single mRNA to synthesize several 
different proteins. Alternative translation initiation includes among others the initiation by a CUG 
codon (Reviewed in Touriol et al. 2003).  
 
It has been examined that some proteins are initiated by a CUG codon. A study by Schwab et al. 
2004 investigated different aspects of CUG initiation. They concluded that the ribosomes also scan 
the mRNA in the 5’-to-3’ direction if the initiation begins with the start codon CUG.  
According to Schwab et al. 2004, a specific ribosome starts the translations initiation when the 
translation initiation codon is CUG. This is further supported by a study by Starck et al. 2012, who 
concluded that some ribosomes are not preloaded with methionine, and can be loaded with leucine 
and form Leu-tRNA-CAG, which can initiate the translation from a CUG codon (Schwab et al., 
2004; Starck et al., 2012).  
Furthermore Schwab et al. 2004 concluded that eIF2α, a subunit of eIF2, is not required when 
translation initiation starts with a CUG codon. When eIF2α is phosphorylated it strongly binds 
eIF2B which prevents the exchange of nucleotides. Schwab et al. 2004 made a phosphorylation of 
the eIF2α, which would normally lead to a decrease in mRNA translation, but no decrease in the 
production of protein translated from a CUG codon was seen (Schwab et al. 2004).  
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The nucleotide composition and the codon sequence surrounding the non-AUG codon have an 
impact on the efficiency of the alternative translation initiation. According to Schwab et.al. 2004 the 
optimal sequence surrounding the CUG codon is TCCACCUGG (Schwab et al. 2004).  
Translation Initiator of Short 5’UTRs 
Normal translation initiation requires the AUG codon to be in a Kozak sequence 20 nucleotides 
from the cap structure (Kozak 1987). When the 5’ UTR is too short for the translation to take place 
by the normal translation initiation process an alternative translation initiation called Translation 
Initiator of Short 5’ UTR (TISU) is described by Elfakess and Dikstein 2008b as a possible 
explanation on translation in short 5´UTR regions.   
TISU makes it possible to initiate translation in genes with at 5’ UTR shorter than 20 nucleotides. 
The average 5’ UTR are 12 nucleotides for genes using TISU (Elfakess and Dikstein 2008). TISU is 
like Kozak a sequence which the ribosome is able to recognize. The TISU sequence is 
𝐶𝐶
𝐺𝐺AA
𝐶𝐶
𝐺𝐺ATGGCGGC (Elfakess and Dikstein 2008). Unlike in normal initiation processes, with 
genes containing a TISU sequence, the ribosome does not scan the mRNA but instead interacts 
directly with the TISU element. This is based on the knowledge that the 40s ribosome binds with a 
higher affinity in a TISU sequence than in a strong Kozak sequence. For the initiation of translation 
without the ribosome scanning the mRNA the sequence from position +6 to +15 plays an important 
role in the translation efficiency (Elfakess et al. 2011).  
Elfakess et.al. 2011 concluded that the 5’ UTR can be as low as to 5 nucleotides without affecting 
the translation efficiency (Elfakess et al. 2011).   
According to Elfakess and Dikstein 2008b when an AUG codon in a TISU sequence is inserted 
upstream to an original AUG translation initiation codon the synthesized protein will only be 
translated from the upstream AUG codon in the TISU sequence (Elfakess and Dikstein 2008).  
Elfakess and Dikstein 2008b also concluded when their examined gene is mutated to have either an 
upstream AUG translation initiation codon in a Kozak sequence or in a TISU sequence upstream to 
an original AUG codon, only their examined gene with the AUG in the TISU sequence does not 
initiate translating from the downstream original AUG codon when the 5’UTR is 12 nucleotides 
long (Elfakess and Dikstein 2008).         
TISU is cap dependent and Elfakess et.al. 2011 showed that if two TISU sequences are in extension 
of each other only the TISU sequence closest to the cap will initiate translation (Elfakess et al. 
2011). 
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mRNA containing a TISU sequence is thought to be more unstable than mRNA without a TISU 
sequence (Elfakess et al. 2011). 
Transcription Factor CDX2 
The Caudal-related homeobox transcription factor 2 (CDX2) is a transcription factor expressed in 
the intestinal epithelium, in the small intestines, and in the colon, where it continues to be expressed 
throughout the lifetime of the cells (Saad et al., 2011; Boyd et al., 2010; Coskun et al., 2011). The 
intestinal epithelium consists of a single layer of cells. Those cells are found in the gastrointestinal 
tract, and are capable of self- renewing. The stem cells are located in the crypts of Lieberkühn, 
where the cell division also takes place. The cells undergo differentiation on their migration from 
the crypt to the luminal surface (Reviewed in Boyd et al. 2010).  
The CDX2 gene is to be found on chromosome 13q12-13, and the CDX2 protein consists of 313 
amino acids. The function of CDX2 is to activate the transcription of some intestine specific 
proteins, which leads to epithelium differentiation (Reviewed in Boyd et al. 2010; Coskun et al. 
2012; Saad 2011). CDX2 is responsible for maintaining the epithelium homeostasis by regulating 
genes related to epithelial functions (Reviewed in Boyd et al. 2010; Coskun et al. 2011).  
 
The activity of transcription factors is strictly regulated to maintain and control the specific gene 
expression in the intestine. Some of the transcription factors are CDX1, CDX2 HNF1α, HNF1β, 
HNF4α and GATA4-6. It has been found that especially HNF1α, GATA4–6, and CDX2 interacts to 
regulate the intestines active promoters (Reviewed in Boyd et al. 2010). 
 
CDX2 is a self-regulating protein (Boyd et al. 2010) and has a positive feedback mechanism on 
itself (Barros et al. 2011). 
 
 
Figure 2: The figure shows the CDX2 in a healthy intestinal epithelial cell, where it activates proteins 
necessary for maturation of the cells. Modified from poster by Dalgaard et al. 
 
CDX2 activates the transcription of certain intestine specific proteins such as MUC2 and 
isomaltase. MUC2 provides the production of mucus, a gel-like barrier produced in the goblet cells 
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(Reviwed in Coskun et al. 2011). Isomaltase is a digestive enzyme, which contributes to digestion 
and absorption of nutrients in the intestine (Reviewed in Moriuchi & April, 1982). The protein 
activation leads to stimulation of intestinal epithelium differentiation, and in general to maintenance 
of the intestine. Also CDX2 up regulates a cyklin-dependent kinase (cdk) inhibitor called 
WAF1/p21. Cdk is a protein kinase involved in the control of cell division as it regulates the 
transcription according to both extra- and intracellular signals (reviewed in Malumbres, 2014). The 
inhibition of cdk prevents inhibition of the epithelial proliferation by preventing the cell cycle to run 
when DNA damage has happened (Reviewed in Saad, R. et al. 2011).  
In general homeobox genes are thought to be proto-oncogenes, but CDX2 is suspected to be an 
exception.  It is observed that in colon cancer, CDX2 is down regulated which among other 
observations have suggested CDX2 as a tumor suppressor. Furthermore studies have shown that 
CDX2 is a specific intestine tumor suppressor gene (Reviewed in Saad, R. et al. 2011). 
vCDX2 
It is detected that the CDX2 gene contains two promoters transcribing two different mRNA, one 
original, and one non-original. Each of those mRNA strands consists of three exons. The original 
CDX2 has an activation domain by the N-terminal and a homeodomain by the C-terminal.  
An isoform of CDX2 (vCDX2) has recently been discovered. The processes of transcribing CDX2 
and vCDX2 are different, as they are initiated by different promoters. 
The vCDX2 also contains a homeodomain but no activation domain.  
CDX2 and vCDX2 are transcribed from the same gene (chromosome 13q12-13). The transcription 
of CDX2 is initiated from a promotor region upstream to exon 1 (figure 3). The transcription of 
vCDX2 is initiated from an alternative promotor region upstream to an alternative exon 1(figure 3) 
(pers.comm Katja Dahlgaard).  
 
 
Figure 3: Schematic presentation of the CDX2 and vCDX2 gene. I = Intron, P = promotor, A.P = alternative promotor, 
Alt. exon1 = alternative exon1 
 
In the mRNA of vCDX2 it has not been possible to find an AUG codon, but instead a possible 
translation initiation CUG codon has been discovered (pers.comm Katja Dahlgaard).  
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There have to be at least 20 nucleotides from the cap structure to the AUG start codon for the 
translation initiation to take place (Kozak 1987), but the CUG codon on vCDX2 is only 13 
nucleotides from the cap structure(pers.comm. Katja Dahlgaard). 
The vCDX2 protein is thought to have a dominant negative affect on CDX2, as it like CDX2 have 
the ability to bind to a promotor region on DNA. Because vCDX2 does not have an activation 
domain it will inhibit the translation initiation when it binds to the promoter region on DNA. It has 
been proven that when vCDX2 is present it binds to the Sucrose Isomaltase promotor and thereby 
inhibits CDX2’s activity because vCDX2 and CDX2 compete on binding to the same promotor 
region (figure 4). This inhibition of the CDX2 activity is thought to be the same for activation of 
other genes, where CDX2 is the transcription factor (pers.comm Katja Dahlgaard).   
 
 
Figure 4: vCDX2 impacts the activity of the Sucrase Isomaltase 
promoter (poster by Dalgaard et al.) 
 
The down regulation of CDX2 will cause a change in the function of the epithelial cells of the 
intestine as the need of CDX2 will affect the differentiation of the cells. This will finally cause the 
intestines to be more exposed for out coming things as the cells do not produce the mucus layer 
since the MUC2 is regulated by CDX2 (Coskun 2013).   
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Figure 5: It is suspected that when the vCDX2 protein is expressed, the activity of the CDX2 
protein will be down regulated, which will impact the maturation of the intestinal epithelial cells 
(modified from poster by Dalgaard et al) 
 
The aim of this project is to investigate whether vCDX2 translation is initiated from a CUG codon 
or an up- or downstream translation initiation site. The investigation has been started since it has not 
been possible to find an AUG translation initiation codon in vCDX2, but instead a possible CUG 
translation initiation codon has been discovered (pers.comm Katja Dahlgaard). 
In previous performed studies they used a plasmid containing the cDNA sequence of vCDX2 and a 
sequence for a FLAG-tag in the same reading frame as the CUG codon (CUGvCDX2).  The plasmid 
was transfected into cells, and protein with a potential translation initiation CUG codon was 
synthesized. Later a site directed mutagenesis of the sequence with the CUG codon was performed, 
and the CUG codon was mutated to an AUG codon. The newly mutated plasmid (AUGvCDX2) was 
transfected into cells and protein was synthesized. By transfection of both the CUGvCDX2 plasmid 
and the AUGvCDX2 plasmid bands were visualized on a Western Blot (figure 6) (pers.comm. Katja 
Dahlgaard).  
 
 
Figure 6: Western Blot visualizing 
protein expressions from 
AUGvCDX2 and CUGvCDX (poster 
by Dalgaard et al). 
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The CUGvCDX2 plasmid synthesized one protein, and the AUGvCDX2 synthesized two proteins. 
One of the proteins synthesized by the AUGvCDX2 plasmid had the same size as the protein 
synthesized by the CUGvCDX2 plasmid, and the other protein synthesized by the AUGvCDX2 
plasmid was smaller in size. This indicates that the translation is initiated from an upstream 
translation initiation site, since two proteins translated from different plasmids had the same size, 
and therefore must be translated from the same translation initiation site. Since one of the proteins is 
smaller this must be the protein translated from the AUG codon. The cells will initiate translation 
from an AUG codon, and since an AUG codon is not found in vCDX2 the synthesized proteins with 
the same and largest size must be initiated from an upstream translation initiation site (pers.comm. 
Katja Dahlgaard).   
Another potential indication could be a different modification of the translated protein depending on 
the first amino acid in the protein being methionine or leucine (pers.comm. Katja Dahlgaard).   
 
To investigate whether vCDX2 starts translation from a CUG codon or from an up- or downstream 
translation initiation site we used three different plasmids. One plasmid had a CUG start codon 
(CUGvCDX2), another plasmid was mutated to have an UUU codon (UUUvCDX2), and a third 
plasmid was mutated to have an UAG stop codon (UAGvCDX2). If the UUUvCDX2 plasmid 
synthesized protein in the same size as vCDX2, it indicated that the protein synthesized was due to 
an up- or downstream translation initiation site. If the UAGvCDX2 plasmid synthesized protein it 
indicated that the translation is initiated from an upstream translation initiation site. 
Problem statement 
Is the mRNA variant of the transcription factor CDX2, named vCDX2’s translation initiated from a 
CUG codon or is the translation initiated from an up- or downstream translation initiation site?   
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Overview of Methods 
As we wanted to investigate whether the vCDX2 translation is initiated by a CUG codon or an up- 
or downstream translation initiation site we designed a set of primers in order to incorporate a UUU 
codon instead of the CUG codon. Furthermore we were assigned a primer set incorporating a UAG 
stop codon instead of the CUG codon.  
The mutations of the template plasmid were done with polymerase chain reaction (PCR). The 
plasmids were infused in E. coli cells for propagation. The right plasmid was identified by 
restriction enzyme digest and the cells containing the right plasmid were propagated in a larger 
volume. Afterwards the plasmids were transfused into cells and Western Blot was performed to 
visualize the possible content of vCDX2 protein. Figure 7 below gives an overview of the 
experiments. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 PCR  
    
 Infusion Cloning  
    
 Mini Prep  
    
 Restriction Enzyme Digestion  
    
 Maxi Prep  
    
 Transfection  
    
 Protein Measurement  
    
 Western Blot  
 
Figure 7: Experimental overview. 
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Materials and Methods 
Primers 
The expression vector pcDNA3.1vCDX2(AUG)-3xFLAG contained an AUG codon and four 
restriction sites for Nco1. For the site directed mutagenesis a primer set were designed to mutate the 
AUG codon to a UUU codon during amplification. 
The primer set was designed in Clontech and synthesized at Eurofins Genomics. The UUUvCDX2 
plasmid is named NAZ in the material and method section and in the result section. Additionally we 
were assigned a primer set incorporating a stop codon UAG instead of an AUG codon, which is 
named KD in the material and method section and in the result section. 
PCR 
The DNA template pcDNA3.1vCDX2(AUG)-3xFLAG was amplified by polymerase chain reaction 
with our primer sets according to the protocol for polymerase chain reaction (Appendix 1). The 
PCR was run according to the program below (table 2).  
The dNTP was from stock in house and 5xPhusion GC buffer and Phusion Hot Star II DNA 
polymerase were both from Thermo Scientific.  
Table 1 shows the volumes and the concentrations of the PCR components. All the reagents, except 
the primer sets were mixed, before separating the mix in two equal parts to which the KD and NAZ 
primer sets were added.  
 
Table 1 – PCR components 
Component 20 µL react. 40 µL react. Final concentration 
H2O  12 µL 24 µL  
5xPhusionGCBuffer  4 µL 8 µL  
10mMdNTPs  0.4 µL 0.8 µL  
Primer KD 1 µL  10 µM 
Primer NAZ 1 µL  10 µM 
Template DNA 4 ng 
pr 20 µl  1.1 µL 2.2 µL 3.6522 ng/µL 
PhusionHot Star II 
DNA Polymerase  0.4 µL 0.8 µL 2 U/µL 
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The PCR was performed on a Thermal cycler from GeneAmp by following the program shown in 
table 2. 
Table 2 - PCR cycles 
Cycle step 2-step protocol  Cycles  Temp. Time 
Initial denaturation  98 °C 45 s 1 
Denaturation 98 oC 
63oC 
72 oC 
30 s 
15 s 
3 min 
1 
Denaturation  
Annealing/Extension  
98 °C 
72 °C 
20 s 
3 min 30 s 
35 
Final extension  72 °C 
4 °C 
7 min 
Hold 
1 
 
To test if the template had been amplified, the product was loaded onto a 1% agarose gel dissolved 
in TAE buffer. The gel was run for one hour at 110V in a gel box with a power supply from VWR. 
The gel was induced on G:Box using GeneSnap program both from SynGene. 
Infusion cloning 
The infusion cloning was performed according to the protocol for In-Fusion® HD Cloning Plus 
(Appendix 2). To 5 µl PCR product was added 2 µl Cloning Enhancer from CloneTech. The mix 
was incubated in a PCR thermal cycler from GeneAmp at 37 °C for 15 min. and afterwards at 80 °C 
for 15 min.  
The Cloning Enhanced treated PCR product was mixed with 5x-Infusion HD Enzyme Premix and 
dH2O to a total volume of 5 µL. Furthermore the template plasmid pcDNA3.1vCDX2(AUG)-
3xFLAG was prepared in a similar way. For details see (Appendix 2). The mixtures were incubated 
for 15 min. at 50 °C in a water bath from VWR and afterward placed on ice for 30 minutes. 
We used E.coli (DH5Xalpha) from ATCC as competent cells for infusion of the plasmids. In an 
Eppendorf tube 1 µL of the mixtures containing the plasmids were added to 100 µL LB medium (in 
house stock). The mixtures were incubated at RT for 25 minutes, put in a water bath at 42 °C for 
one minute, and then placed on ice.  
The LB plates (in house stock) were dried at 37 °C in 10 minutes, and the samples containing cells 
and infusion cloning mix was spread on the plates. All the plates contained ampicillin, except for 
the LB control plate which only contained LB. Plates were prepared as in table 3 in results. 
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The cells grew overnight at 37 °C. From the sample plate (KD1) 12 colonies were harvested for 
further purification. The remaining of the 12 harvested colonies were stored in the refrigerator at 4 
°C in LB media. Due to lack of results for cells infused with NAZ plasmids we decided to only 
continue with the KD plasmid. 
Purification of plasmids 
The plasmid was purified by use of Quick plasmid MiniPrep kit from Invitrogen. For details see 
Appendix 3. The purified plasmid was stored in freezer until use.  
Restriction enzyme digestion 
In order to control if the plasmid purified by use of MiniPrep contained the desired sequence, a 
control cutting was performed. The concentrations of purified plasmid were measured on 
NanoDrop® Spectrophotometer ND-1000 at 260 nm. 
1.5 µL Tango buffer 10X and 0.7 µL restriction enzyme NcoI 500U, both from ThermoFisher 
Scientific, were mixed with 500 ng plasmid and water to a total volume of 20 µL. 
The samples were incubated for 2 hours at 37 °C. It was tested on a 1% agarose gel dissolved in 
TAE buffer if the correct plasmid had been amplified. To 20 µL of sample was added 4 µL loading 
buffer 6X from Thermo Scientific. The ladder was Thermo Scientific GeneRuler 1 kb plus DNA 
ladder (0.1 µg/µL). 
Amplification and Maxi prep 
Amplification of infused cells with the KD plasmid was done by pipetting 100 µL of the harvest 
cell culture into 5 mL LB media (in house stock) and 5 µL ampicillin. The samples were incubated 
for 6 hours at 37 °C. After incubation 300 µL of the samples, were added to 300 mL LB media with 
ampicillin in the ratio 1000:1 in 1 L conical flask. The cells were incubated overnight at 37 °C. 
Plasmids were purified by use of Maxi Prep (NucleoBond®) according to protocol (Appendix 5). 
The concentrations of purified plasmid were measured on NanoDrop® Spectrophotometer ND-
1000 at 260 nm, and stored in freezer until transfection. 
Transfection 
The plasmid purified by use of MaxiPrep was transfected into 3 different cell lines: DLD1, HeLa 
and Hek all from ATCC. Cells were grown in DMEM media from Bio Whittaker. Additionally two 
other plasmids (UUU and CUG) were transfected into the three cell lines according to the protocol 
for transfection (Appendix 9).  
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In total we had 4 different plasmids to be transfected into 3 different cell lines, leaving 3 different 
wells per plasmid.  For each well a total volume of 100µL plasmid was prepared to a concentration 
of 1,2µg/µL plasmid in 150 mM NaCl. 100µL plasmid was mixed with 100µL 2µM PEI25 (in 
house stock) diluted in 150mM NaCl and incubated for 2 hours at RT, to ensure the PEI and 
plasmids to form precipitate. To each well was added 200µL of the PEI treated plasmids. 
The cell cultures with the PEI treated plasmid were grown in 6 wells plate  in DMEM media from 
Bio Whittaker for 48 hours at 37 °C in Heracell 150 incubator. The media was changed after 24 
hours. 
Protein measurement  
The cells were lysed by use of RIPA buffer (in house stock) according to protocol (Appendix 6). 
Additionally the cells were lysed by a piston from Kimble & Chase. 
After purification by centrifugation at 12,000 g, the concentrations of proteins were measured by 
use of Pierce® BCA protein assay kit from Thermo Scientific according to the protocol for 
microplate procedure (Appendix 6), with RIPA buffer as diluent. All samples were done in 
triplicates, including the standard row. The absorbance was measured on Synergy HT from Bio-
Tek. Calculations were performed in Excel.  
Western Blot 
The SDS electrophorese was performed on Bolt®Bis tris 4-12% (MES) from Novex in Bolt Mini 
gel tank according to protocol (Appendix 7). Running buffer was MES SDS running buffer from 
Novex. The Bolt Sample Reducing Agent and LDS sample buffer was from Novex. The gels were 
loaded with 244,8 µg/mL, 201,8 µg/mL and 186,8 µg/mL protein, and run at 200V for 15 minutes 
and 150V for 30 minutes with Page ruler no. 26616 ladder from Thermo Scientific.  
The blot was performed on Xcell II blot module from Novex according to protocol (Appendix 8). 
Transfer buffer was from NuPAGE, and the transfer was run at 20V for one hour. 
The protein was detected by incubating the membrane with the primary antibody Monoclonal anti-
FLAG from Sigma until next day, where the blots were washed and incubated for one hour with a 
secondary antibody Anti-mouse mono HRP from abcam. The protein was detected on G:Box from 
SynGene with Genesnap also from SynGene.  
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Since the results were inconclusive, we stripped the membrane. We incubated until the next day 
with primary antibody anti-vinculin from Abcam and afterwards we incubated with the secondary 
antibody goat-anti-rabbit poly HRP from Pierce.  
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Results 
A plasmid containing the cDNA sequence of vCDX2 and a sequence for a FLAG-tag in the same 
reading frame as the CUG codon in vCDX2 has in previous experiments after transfection into cells 
synthesized protein with CUG as a potential translation initiation codon. After a site directed 
mutagenesis of the CUG codon to an AUG codon two bands of protein were visualized on a 
Western Blot. One of the synthesized proteins had the same size as the protein synthesized by the 
CUGvCDX2 plasmid, and the other protein had a smaller size. Since one of the proteins synthesized 
by the AUGvCDX2 plasmid had the same size as the protein synthesized by CUGvCDX2 it could be 
suspected that the protein synthesized by the CUGvCDX2 was initiated from an upstream translation 
initiation site and the smaller protein was synthesized from the mutated AUG codon.  
To investigate whether vCDX2 translation is initiated from a CUG codon or an up- or downstream 
translation initiation site we used three different plasmids. By use of a self-designed primer set, we 
mutated one of the plasmids to have a UUU codon instead of the original CUG codon. Another 
plasmid was mutated to have a UAG stop codon instead of the original CUG. This was done by use 
of a primer set which we did not design ourselves. By use of PCR we mutated and amplified our 
plasmids.  
After our plasmids were mutated and amplified they were transformed into E. coli (DH5Xalpha) to 
achieve further amplification of the plasmids.  
A purification of the plasmids was necessary before transfection into human cells could take place. 
After transfection a protein measurement was performed and to control if any vCDX2 had been 
synthesized a Western Blot were made. If any protein was synthesized from the UUUvCDX2 
plasmid, the previous found vCDX2 was initiated from an up- or downstream translation initiation 
site. If any protein was synthesized from the UAGvCDX2 plasmid the previous found vCDX2 was 
initiated from an upstream translation initiation site.   
Design of primer sets for site directed mutagenesis of plasmids  
We designed our primer set to enable a site directed mutagenesis of our plasmids by a PCR. The 
site directed mutagenesis was done by amplification of template DNA pcDNA3.1vCDX2(AUG)-
3xFLAG. Two sets of primers mutated the plasmid from having the start codon AUG to UUU and 
from AUG to UAG ending up with two different plasmids.  
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The mutations were made to enable an investigation of whether the previous vCDX2 findings were 
caused by a CUG codon or an up- or downstream translation initiation site. 
 
We synthesized a forward and a reverse primer for site directed mutagenesis. The designed NAZ 
primer set was as follows: 
Forward primer: 5’-TCGCTTTTTTCGTCACTGTGCACATGCTAGGGA-3’ 
Reverse primer: 5’-TGACGAAAAAAGCGAGCCCAGGAATTCCACCAC-3’  
 
We were assigned a primer set with a stop codon TAG instead of an AUG start codon. The assigned 
KD primer set was as follows:   
Forward primer: 5´- CGCTTTTAGCGTCACTGTGCACATGCTAGGGAG-3´ 
Reverse primer: 5´- GTGACGCTAAAAGCGATGCCCAGGAATTCCACC-3´ 
 
To make sure that the plasmids had been amplified the PCR product was run on a gel.  The 
amplification results are shown in Figure 8 and Figure 9. 
 
 
Figure 8: PCR gel which shows the site directed 
mutagenesis from the primer sets NAZ and KD. 
 
Figure 9: Enlarged areal of the gel.
 
As seen in figure 8 and figure 9 the amplification was done successfully as two bands at the correct 
size are visualized. Primer-dimers for the NAZ primer set were also noticed, indicating the PCR has 
to be optimized either with a change in annealing temperature or numbers of cycles (Das, 
Mohapatra, and Hsu 1999; Don et al. 1991). 
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Infusion of plasmids into E.coli bacteria for amplification 
By use of infusion cloning we infused our plasmids into E. coli (DH5Xalpha) bacteria for further 
plasmid amplification thus later transfection was possible.   
After the successful amplification the two different plasmids were treated with cloning enhancer. 
First the temperature was 37 °C in order to remove the original template, and then it was increased 
to 80 °C in order to degenerate the enzyme (cloning enhancer). The mixtures were incubated for 15 
min. at 50 °C in a water bath from VWR in order to construct a new circular plasmid, and afterward 
placed on ice for 30 minutes. Afterward the cloning enhanced treated plasmid were infused into E. 
coli (DH5Xalpha) bacteria and following plates were made for the infusion (table 3). 
Table 3 - infusion cloning plates 
Plate 
no. 
Control Content on the plates Purpose 
KD1& 
NAZ1 
Sample Cloning enhanced treated 
plasmids. 
The plasmid is transformed into the 
cells 
KD2& 
NAZ2 
Positive control 1µl pcDNA3.1vCDX2-
3xFLAG.   
In order to test if the cells were 
competent to infuse the plasmids, we 
added the template instead of our 
cloning enhancer-treated PCR fragment. 
If no colonies were formed on the plate, 
it was because our E. coli was not 
capable of infusing the plasmids. 
KD3& 
NAZ3 
Negative 
control.  
Minus 5Xinfusion HD 
enzyme premix. Plus 
cloning enhancer treated 
PCR fragments 
To test the cloning enhancer. Cloning 
enhancer removes template residues.  
If no colonies were formed on the plates 
the cloning enhancer worked properly.  
KD4& 
NAZ4 
Negative 
control without 
DNA 
Minus plasmid We did not add plasmid and added 
water instead. This was to test if the 
samples had been contaminated. If 
colonies were formed on the plates our 
samples had been contaminated.  
5 LB control E. coli (DH5Xalpha) To test if the DH5Xalpha bacteria grew on plate without ampicillin.  
6 
LB and 
Ampicillin 
E. coli (DH5Xalpha) To test if the DH5Xalpha bacteria that 
had not been transformed with the 
plasmid making them ampicillin 
resistant grew.  
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After incubation overnight colonies were harvested. Table 4 shows the numbers of colonies on each 
plate.  
Table 4 - Number of colonies on the plates 
Plate KD1 KD2 KD3 KD4 NAZ1 NAZ2 NAZ3 NAZ4 5 6 
Nr. of 
colonies 12 >500 3 0 0 >500 0 0 >500 0 
 
The growth of colonies on the plates KD2 and NAZ2 shows that the cells were competent to 
transform the plasmids. The growth of colonies on plate KD3 shows that the cloning enhancer 
worked properly. The missing growth of colonies on plates KD4 and NAZ4 shows that our samples 
were not contaminated. The missing growth of colonies on plate 6 shows that bacteria lacking the 
gene coding for ampicillin resistant cannot grow. As it is shown in table 4 the infusion cloning was 
only successful for the KD plasmid, since no colonies were seen on the plate where E. coli were 
infused with the NAZ plasmid. For that reason only colonies from plate KD1 were used. In total 12 
different colonies from KD1 plate were isolated and additional purified by use of MiniPrep. 
Use of restriction enzyme to analyze if the correct plasmid had been amplified  
To analyze if the correct plasmid had been amplified in E. coli, the purified plasmid was digested 
by the restriction enzyme NcoI. The purpose of the restriction enzyme digest was to choose which 
of the bacteria colonies we wanted to propagate and purify by use of Maxi Prep. The chosen 
bacteria colonies are the ones where the restriction enzyme digest shows three bands on the gel. 
This was done to ensure only the mutated plasmids were transfected into the bacteria.  
 
Nco1 recognizes the sequence 5´C↓CATGG 3´ and cuts at the arrow (ThermoFisher Scientific). If it 
was the template plasmid with the AUG start codon that had been amplified four bands with the 
sizes 361 bp, 735 bp, 1523 bp and 3342 bp would be visualized. If it was the mutated plasmid that 
had been amplified three bands with the sizes 735 bp, 1884 bp, 3342 bp would be visualized. 
The plasmid concentrations from the 12 different colonies of the KD1 plate were determent on 
Nanodrop and table 5 shows the different concentrations. For the control cutting a concentration of 
500ng/µL plasmid was needed. Table 5 shows the dilution of the purified plasmid with water in 
order to achieve a plasmid concentration at 500 ng/µL. 
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Table 5 - control cutting 
Number 
Plasmid 
concentration 
ng/µL 
Volume 
plasmid 
µL 
Volume 
water 
µL 
KD1 82.1 6 11.7 
KD2 55.2 9.1 8.7 
KD3 68.8 7.3 10.5 
KD4 66.4 7.5 10.3 
KD5 92.5 5.4 12.4 
KD6 59.0 8.5 9.3 
KD7 184.1 2.7 15.1 
KD8 104.6 4.8 13.0 
KD9 82.5 6.1 11.7 
KD10 89.7 5.6 12.2 
KD11 36.1 13.9 3.9 
KD12 87.5 5.7 12.1 
 
The Nco1 treated plasmids were run on a gel and figure 10 shows the results of the control cutting. 
 
 
Figure 10: The picture shows the control cutting of the plasmids purified by use of MiniPrep.  
 
As seen in figure 10 seven samples had the correct number of bands at the right size. Five samples 
showed a band size at 1523 bp and it is possible to faintly see the fourth band. Two samples (KD7 
and KD11) were chosen for amplification and bacterial cultures were incubated overnight (table 6) 
and purified by use of Maxiprep.  
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Table 6 – Overnight culture for MaxiPrep 
Culture 
number 
LB medium 
volume 
mL 
Ampicillin 
added µL 
Cell culture added 
µL 
KD7 290 290 300 
KD11 295 295 300 
 
Transfection of plasmids into human cells to start protein synthesis 
KD7 and KD11 were, together with UUUvCDX2 plasmid and CUGvCDX2 plasmid, transfected into 
three different cell lines; Hek, HeLa and DLD1. This was to start the protein synthesis of the 
plasmids.  
For transfection we used three six wells plates. One well on each plate contained only the cells 
(HeLa, Hek og DLD1), and worked as a control to test for contamination (table 7).  
 
Table 7 - Transfection 
Cell line 
Plasmid 
UUU 
 
CUG 
561 
KD7 
UAGvCDX2 
KD11 
UAGvCDX2 No DNA 
Hek 
P:7 
Cell concentration 
300,000 
 
1 µg 1 µg 1.2 µg 1.2 µg 1 µg 
HeLa 
P: 
Cell concentration 
300,000 
1 µg 1 µg 1.2 µg 1.2 µg 1 µg 
DLD1 
P:6 
Cell concentration 
300,000 
1 µg 1 µg 1.2 µg 1.2 µg 1 µg 
 
After 48 hours the cells were lysed. It was noticed that none of the wells had a cell culture there 
were confluent at a high level (60-80%).  
Protein measurement to ensure an even concentration of protein on the Western 
Blot 
As we wanted to control the amount of protein synthesized in the different cell lines containing the 
different plasmids, we made a protein purification followed by a protein measurement. The 
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measurement was made to ensure that an even concentration of protein was loaded onto the gel 
when Western Blot was performed. To measure the amount of synthesized protein we made a 
standard curve. 
The standard curve for the Pierce BCA protein assay (figure 11) constituted the background for 
calculation of the concentration of protein in the transfected cells as well as the cells that was not 
transfected.  
 
Figure 11: Standard curve for Pierce BCA protein assay 
 
Table 8 shows the average absorption for the protein measurement for the different transfected cell 
lines and the calculated protein concentration based on the standard curve. 
 
Table 8 - Protein concentration 
 Average absorption  Protein concentration µg/mL 
Plasmid HeLa Hek DLD1 HeLa Hek DLD1 
UUU 0.559 0.523 0.434 316.8 280.5 191.8 
KD7 0.508 0.487 0.429 265.3 244.8 186.8 
KD11 0.582 0.512 0.467 339.5 269.8 224.5 
561 0.444 0.589 0.479 
 
201.8 346.8 236.8 
Cells 0.525 0.661 0.512 282.5 418.8 270.1 
 
y = 0.001x + 0.2422
0
0.5
1
1.5
2
2.5
0 500 1000 1500 2000 2500
ab
s
conc µg/mL
Standard curve
28 
 
 
Figure 12:  Protein concentration of transfected cells. 
 
As a result of the measured protein concentrations (table 8 and figure 12), two separate gels were 
loaded with different protein concentrations. Gel no. 1 was loaded with a protein concentration of 
6.42 µg protein, while gel no. 2 was loaded with 5.26 µg protein and 5.27 µg protein. The order of 
loading the samples and concentrations are shown in table 9 and table 10. 
 
Table 9 - Gel no. 1 Protein concentration after dilution 244.8 µg/ml 
Concentration Loaded on the gel :  6.42 µg 
1 2 3 4 5 6 7 8 9 10 
Ladder HELA 
UUU 
HELA 
KD7 
HELA 
KD11 
HELA 
-DNA 
HEK 
UUU 
HEK 
KD7 
HEK 
KD11 
HEK 
561 
HEK 
-DNA 
 
Table 10 - Gel no.2: Protein concentration after dilution: Wells no. 2-5: 201.8 
µg/mL. Wells no.6 and 7: 186.8 µg/mL. 
Concentration loaded on the gel: 2-5: 5.26 µg. 6-7: 5.27 µg.  
1 2 3 4 5 6 7 8   
Ladder DLD1 
KD11 
DLD1 
561 
DLD1 
-DNA 
HELA 
561 
DLD1 
UUU 
DLD1 
KD7 
Ladder   
 
  
Plasmids 
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Western Blot for visualization of possible synthesized vCDX2 protein  
We made two Western Blots to visualize a possible synthesize of vCDX2 protein.  
Our vCDX2 had a 3x-FLAG sequence, which the primary antibody Monoclonal anti-FLAG would 
be able to detect. A secondary antibody Anti-mouse mono HRP was added to visualize vCDX2.  
The first blot contained the samples with the highest protein concentration 6.42 µg and one ladder 
(figure 13 and figure 14). As seen from figure 14, no protein was visualized. The second blot is 
shown in figure 16 as for the first blot no protein was visualized.  
 
Figure 13: Western Blot Gel no.1. The figure 
shows the ladder. 
 
Figure 14: Western Blot Gel no. 1. The protein 
concentration loaded on the gel was 6.42 µg for 
each of the samples.
 
Figure 15: Western Blot Gel no. 2. The figure 
shows the ladder. 
 
Figure 16: Western Blot Gel no.2. For well 2-5 
the concentration loaded was 5.26 µg protein. 
For well no. 6 and 7 the concentration was 
5.27 µg protein.  
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Since no bands were visualized, a stripping was performed and a new Western Blot was done. The 
new Western Blots were done with anti-vinculin as the primary antibody. The stripping was done to 
ensure that proteins had been transferred to the blot.  
As seen in figure 18 for gel no.1 and in figure 20 for gel no.2 bands was visualized.  
 
 
 
Figure 17: Western Blot gel no.1 vinculin. The 
figure shows the ladder. 
 
Figure 18: Western Blot Gel no. 1 vinculin.
 
 
Figure 19: Western Blot Gel no. 2. The figure 
shows the ladder. 
 
Figure 20: Western Blot Gel no. 2 vinculin.
The results show that protein was indeed transferred to the blot, but there were no useful results for 
the vCDX2 protein.  
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Discussion 
A plasmid which contains the cDNA sequence of vCDX2 and a sequence coding for a FLAG-tag in 
the same reading frame as the CUG codon in vCDX2, has in a previous study been discovered to 
synthesize a protein after transfection of the plasmid into cells. Based on the previous study vCDX2 
is suspected to have a CUG translation initiation codon. After site directed mutagenesis of the CUG 
codon to an AUG codon two proteins of different size were synthesized. One of the proteins had the 
same size as the protein synthesized from the CUGvCDX2 plasmid and the other synthesized protein 
was of a smaller size. This could indicate that the translation of vCDX2 is initiated from an 
upstream translation initiation site, or that the modification of the translated proteins are different 
depending on the first amino acid in the protein being either methionine or leucine.  
In our experiment we wanted to investigate whether the protein translated from vCDX2 is initiated 
from the CUG codon or an up- or downstream translation initiation site. We wanted to examine this 
by mutating pcDNA3.1vCDX2(AUG)-3xFLAG plasmids from having an AUG codon to have 
either a UUU codon, or a UAG stop codon, as we wanted to examine if the plasmids would still 
synthesize protein in the same size as vCDX2 after a mutation. An amplified CUGvCDX2 plasmid 
and our amplified mutated plasmids UUUvCDX2 and UAGvCXD2 were transfected into three 
different cell lines; Hek, HeLa and DLD1.  
If any vCDX2 protein were synthesized from the UUUvCDX2 plasmid, it would indicate that 
translation of vCDX2 is initiated from an up- or downstream translation initiation site. If any 
vCDX2 protein were synthesized from the UAGvCDX2 plasmid, it could indicate that translation of 
vCDX2 is initiated from an upstream translation initiation site.    
Unusable detection of vCDX2 on the Western Blot 
As shown in figure 14 and figure 16 no detection of vCDX2 was visualized on the Western Blots. 
Consequently it is not possible on the basis of our experiment to discuss whether the translation of 
vCDX2 is initiated from a CUG codon or an up- or downstream initiation site.  
To ensure that any protein had been synthesized and transferred to the blot we performed a new 
antibody staining that was able to detect vinculin. As shown in figure 18 and Figure 20 bands were 
visualized. This established that protein had been transferred to the blot, but vCDX2 had not been 
synthesized or had not been transferred.   
The lack of vCDX2 may be due to an unsuccessful transfection.  It is possible to add a fluorescent 
substance during the transfection. This is done to enable a calculation of the transfection efficiency 
and thereby to control if the transfection of the plasmids into the cells has been successful.  
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When we made the transfection no fluorescent substance was added. The lack of fluorescent 
substance made it impossible to determine if the plasmids had been transfected into the three cell 
lines. If the transfection of the plasmids failed, it would not be possible to detect vCDX2, since the 
primary antibody had to bind to the FLAG-tag, and on the Western Blot only vCDX2 protein 
containing the FLAG-tag will be visible. This means that the potential vCDX2 synthesized by the 
cells own genes will not be visible since they do not carry the FLAG-tag.  
The lack of vCDX2 can also be due to a too low amount of protein. The highest concentration of 
protein loaded on the SDS gel was 6.42 µg. It is recommended that the protein concentration in the 
SDS gel for Western Blot has to be at least 10 µg of protein per well (pers.comm. Helle Jensen). 
The concentration loaded on the gels is the total protein concentration in the cells. This means that 
the vCDX2 concentration is even lower, which could mean that the loaded concentration of vCDX2 
is extremely low, and under the detection limit.  
The low protein yields from the cells can be due to the state of the cells. We did not see a confluent 
cell growth after 48 hours. This could be due to the media, the generation of the cells or something 
else. 
The staining with the antibodies for the Flag-tagged vCDX2 in the Western Blot can also contribute 
to the poor result, as we do not know how the antibodies has been stored and handled. If the 
antibody has been mistreated it may not have worked properly. This could result in a lack of 
binding and a visualization of vCDX2 protein would not be possible.  
Translation Initiation of vCDX2 
It is generally assumed that translation is initiated from an AUG codon (Reviewed in Touriol et al. 
2003), but vCDX2 translation is thought to be initiated from a CUG codon (pers. comm. Katja 
Dahlgaard).  
Schwab et.al. 2004 have concluded that the translation of the LTFNYRNL peptide is initiated from 
a CUG codon. They further concluded that for an efficient CUG translation initiation, the CUG 
codon has to be in a strong Kozak sequence. For CUG translation initiation a strong Kozak 
sequence is TCCACCCUGG. This was examined by mutating the nucleotides at position -6, -3 and 
+4 in the nucleotides surrounding the CUG codon in the SEL8 pcDNAI vector which were 
transfected into COS-7 cells. It was determined which of the transfected cells had the most efficient 
translation initiation, by examining which of the transfected cells that gave the strongest T-cell 
response (Schwab et al. 2004).      
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The vCDX2 gene does not have the CUG in a strong Kozak sequence as the sequence surrounding 
the CUG codon is CGCTTTCUGC (Appendix 10).  
 
 
Figure 21: The sequence surrounding the CUG codon in vCDX2 
 
Even if the CUG codon had been in a strong Kozak sequence the CUG codon is only 13 nucleotides 
from the cap structure (Pers. comm. Katja Dahlgaard). According to Elfakess and Dikstein 2008, 
the initiation of translation in a strong Kozak sequence is weakened when the 5’ UTR is smaller 
than 12 nucleotides (Elfakess et al. 2011). No strong Kozak sequence is found upstream from the 
CUG codon. Since it is suspected that the translation is initiated from an upstream translation 
initiation site a strong Kozak sequence could otherwise have indicated this.    
According to Kozak 1990 translation initiation in a weak Kozak sequence can be enhanced if it is 
followed by a guanine and cytosine rich sequence 12 to 15 nucleotides from the translation 
initiation codon. Since guanine and cytosine rich sequences has the potential of forming a hairpin 
structure which will give the ribosome more time to recognize the translation initiation codon. This 
was examined by mutating SP64-CAT to have an extra AUG codon upstream from the translation 
initiation codon and add extra guanines and cytosines from 2 to 32 nucleotides downstream from 
the translation initiation codon (Kozak 1990). Schwab et.al. 2004 suggest that the same apply for 
translation initiated from a CUG codon (Schwab et al. 2004). 
The vCDX2 does not have a rich guanine and cytosine sequence 12 to 15 nucleotides downstream to 
the CUG codon. This indicates that the translation initiating is not helped by a hairpin structure 
downstream to the CUG codon. Neither was any guanine and cytosine rich sequences found in 
vCDX2 upstream from the CUG codon. This could otherwise have indicated that the translation was 
initiated from an upstream translation initiation site.   
Translation Initiation of Short 5’UTRs 
The 5’ UTR has to be at least 20 nucleotides and an AUG start codon has to be placed in a strong 
Kozak sequence for normal translation initiation (Kozak 1987). vCDX2 does not fulfill these 
standards, as it only has 13 nucleotides from the cap structure to what is thought to be the initiation 
translation codon, and the codon is furthermore not AUG but CUG. As described above it is 
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possible for translation to be initiated from a CUG codon but there are still only 13 nucleotides from 
the cap structure to the CUG codon. This has made people doubt whether it is possible that 
translation of vCDX2 can be initiated from a CUG codon. A potential way initiation from a short 5’ 
UTR could be possible is if the CUG codon is in a TISU sequence. Elfakess et.al. 2011 concluded 
that if the AUG translation initiation codon is placed in a TISU sequence it is possible for the 5’ 
UTR to be only 5 nucleotides long. This was examined by inserting a 5’ UTR to be 5, 8 or 11 
nucleotides long in a TISU sequence (Elfakess et al. 2011). These findings has however been 
identified where the translation initiation codon has been AUG. The TISU sequence is 
𝐶𝐶
𝐺𝐺
AA𝐶𝐶
𝐺𝐺
ATGGCGGC (Elfakess et al., 2011; Elfakess & Dikstein, 2008).  
vCDX2 does not have a CUG codon in a TISU sequence, and no TISU sequence upstream to the 
CUG codon is found. If an upstream TISU sequence had been observed it could have indicated that 
the translation was initiated from an upstream translation initiation site. 
The length of the 5’ UTR is longer in our plasmid than the 13 nucleotides. The translation initiation 
could therefore be different in vivo than in our experiment. The length from the cytomegalovirus 
(CMV) promotor to the CUG codon is 152 base pair. According to Elfakess and Dikstein 2008 the 
stability of the translation efficiency does not decrease when the 5’ UTR is lengthened to up to 60 
nucleotides. This indicates that the translation initiation in a TISU sequence would not be affected 
by a lengthened 5’ UTR.  
Primer-dimer 
The site directed mutagenesis for NAZ primers gave a low yield and formation of primer-dimers 
(Figure 8).  Besides the one presented in this report we had also run some previous PCR, but the 
reaction did not give any results except for primer-dimers. When introducing an extra step in the 
PCR we got a result, albeit a low yield and formation of primer-dimers. Some further work on 
adjusting the annealing temperature would probably give a higher yield of PCR product.  
Primer-dimers occur when primers anneal to each other (Das et al. 1999; Rychlik 1995) and its 
formation are depended upon the annealing temperature and the length of the primers, where shorter 
primers tend to form more primer-dimer (Das et al. 1999; Rychlik 1995).  
A primer-dimer is short and therefore it can anneal to multiplied sites on the template resulting in 
nonspecific DNA synthesis and as a consequence a lower yield of PCR product (Das et al. 1999; 
Rychlik 1995). 
35 
 
There are several ways to avoid the formation of primer-dimers by adjusting the PCR conditions in 
order to optimize the synthesis. E.g. the mixture of the reagent, the temperature (Don et al. 1991) 
and the length of the individual PCR steps can be changed (Das et al. 1999; Rychlik 1995).  
 
We did not succeed in infusing the UUUvCDX2 plasmid in E.coli. Since all the controls were good 
and as expected (table 4), it is reasonable to believe that the lack of cell growth is due to low 
concentration of UUUvCDX2 plasmids from the site directed mutagenizes.  
In written hour we still await the sequencing of the UUUvCDX2 plasmid to be done. The sequencing 
can determine whether something unintended happened during the PCR. 
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Conclusion 
Since we did not get any detection of our FLAG-tagged vCDX2 on the western blot it is on the 
basis of our project not possible to conclude whether the translation of vCDX2 is initiated from a 
CUG codon or an up- or downstream initiation translation site. 
Previous studies have shown that when the CUG codon in a plasmid containing the cDNA of 
vCDX2 and a sequence for a FLAG-tag in the same reading frame as the CUG codon is mutated to 
an AUG codon two proteins are synthesized. One of the proteins synthesized by the AUGvCDX2 
plasmid had the same size as the protein synthesized from the CUGvCDX2 plasmid. The other 
protein synthesized by the AUGvCDX2 plasmid was smaller than the protein synthesized by the 
CUGvCDX2 plasmid. This could indicate that the translation of vCDX2 is initiated from an upstream 
translation initiation site. On basis of the used literature it does, on the other hand, not indicate that 
translation can be initiated from an upstream translation initiation site. Since vCDX2 does not 
contain a TISU sequence or and 5’ UTR above 20 nucleotides.  
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Perspective 
As we did not get any detection of vCDX2 further studies should be performed examine if vCDX2 
is initiated from a CUG codon or an up- or downstream translation initiation site. 
If a later project will be able to conclude that the translation of vCDX2 is initiated from a translation 
initiation site up- or downstream to the CUG codon further studies would have to be made in search 
of the translation initiation codon.  
If a later project concludes that the translation of vCDX2 is initiated from a CUG codon it could for 
further studies be interesting to investigate if the smaller protein found when the CUG codon is 
mutated to an AUG codon is due to differences in the protein modification.   
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Appendix 1 - Protocol for polymerase chain reaction PCR  
 
1. Prepare master mix – for two reactions 
Component 20 µL reactant  40 µL reactant Final concentration 
H2O  24 µL  
5x Phusion GC Buffer 4 µL  8µL  
10 mM dNTPs 0.4 µL  0.8µL 10mM*0.8µL/40 
µL=  
0.2 mM 
Primer NAZ (10µM) 1 µL (v1 = (20 µL*0.5 
µM)/10 µM) 
 0.5 µM 
Primer KD (10µM) 1 µL (v1 = (20 µL*0.5 
µM)/10 µM) 
 0.5 µM 
Template DNA  
Plasmid 
pcDNA3.1vCDX2-
3xFLAG 4 ng pr 20 µL 
1.1 µL Conc. 3,6522 ng/µl 2.2µL 4.02 ng/µL 
Phusion Hot Star II DNA 
Polymerase (2 U/µL) 
0.4 µL  0.8 µL 2U/µL*0.8µL/40µL= 
0.04U/µL 
 
2. Mix H2O, 5x Phusion HF Buffer, dNTPs, template DNA and Phusion Hot Star II DNA Polymerase. 
Divide it in two with 19 µL in each PCR-tube.  
3. Add primers to each tube 
4. Gently mix the components together 
 
PCR cycles  
Cycle step 2-step protocol Cycles 
Temp. Time 
Initial denaturation 98 °C 45 s 1 
Extra step 980C 
63oC 
72oC 
30 s 
15 s 
3 min 
1 
Denaturation 
Annealing/Extension 
98 °C 
72 °C 
20 s 
3 min 30 s 
35 
Final extension 72 °C 
4 °C 
7 min 
Hold 
1 
 
The Primers have a concentration at 100 µM. The primers have to be diluted 1:9 in order to achieve a primer 
concentration at 10 µM. 1 µL primer and 9 µL water. 
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Calculation  
The start concentration of the template plasmid (pcDNA3.1vCDX2(AUG)-3xFLAG) is 36522 
ng/µL. For the experiment a concentration of 4 ng plasmid per reaction was needed. In order to 
achieve a concentration of 4 ng plasmid, 1 µL plasmid was diluted in 100 µL water resulting in a 
concentration of 36.522 ng/µL. 1µL of plasmid with a concentration of 36.522 ng/µL was diluted in 
10 µL water ending with a final concentration of 3.6522 ng/µL. 
 
We needed to add 4 ng plasmid to the reaction: 4 ng3.6522ng/µl = 1.1 µl diluted templated plasmid (pcDNA3.1vCDX2(AUG) − 3 ∗ FLAG 
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Appendix 2 - Protocol for Infusion cloning In-Fusion® HD Cloning 
Plus 
 
1) Add 1 µL of Cloning Enhancer to the 2.5 µL of PCR product 
2) Incubate at 37 °C for 15 min. 
3) Incubate at 80 °C for 15 min. 
4) Make sure to save some cloning enhancer treated fragments for the negative control  
control of the cloning enhancer 
5) Set up In-Fusion cloning reaction 
 
Component Volume 
5x In-Fusion HD Enzyme 
Premix 
1 µL 
Cloning Enhancer-Treated 
PCR Fragment 
1 µL 
dH2O 3 µL 
Total volume 5 µL 
 
6) Incubate at 50 °C for 15 min.  In PCR thermal cycler 
7) Place on ice 
8) Competent cells:  
- 4 eppendorf tubes : 
- Normal: Mix cells and cloning mix 
-  control Mix cells: We have a tube with the positive control, to test the competent cells 
by using DNA template(positive) 
- Control Mix cells: We have a tube with negative control, to test the cloning 
enhancer(negative) 
- We have a tube without template DNA to test for contamination  
Mixtures according to table below were prepared: 
  
In PCR thermal cycler 
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Infusion cloning 
PCR product, 
Sample KD1 KD2 KD3 KD4 NAZ1 NAZ2 NAZ3 NAZ4 
Component 
5x In-Fusion HD 
Enzyme Premix in 
µl 
1 1 0 1 1 1 0 1 
Cloning Enhancer-
Treated PCR 
Fragment µl 
1 0 1 0 1 0 1 0 
dH2O µl 3 3 4 4 3 3 4 4 
DNA template µl 0 1 0 0 0 1 0 0 
Total volume µl 5 5 5 5 5 5 5 5 
 Normal 
Positiv
e 
control 
Negativ
e 
control 
No 
DNA 
Norma
l 
Positiv
e 
control 
Negati
ve 
control 
No 
DNA 
 
9) Incubate for 30 mi.  
10) heat shock  at 42 °C in 1 min 
11) On ice in minimum 3 min 
12) add 100µL LB media and incubate for 15 min. at room temperature 
13) Spread each sample on a separate LB plate containing ampicillin. Additional two plates: one 
with ampicillin and one plate with LB media.  
14) Incubate all of the plates over night at 37 °C 
15) Pick individual isolated colonies from each experimental plate 
16) Add ampicillin to LB media 100µL/mL 
17) Add one colony to 4 mL LB media.  
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Appendix 3 - Protocol for Quick plasmid MiniPrep kit from 
Invitrogen  
 
Preparations: Lysis buffer and wash buffer was prepared.  
1) Harvest:  
Centrifuge 1.5 mL and 1.3 ml (at room temperature using a microcentrifuge) of the 
overnight LB-culture. (Use 1–2 × 109 E. coli bacteria for each sample.) Remove all medium. 
2) Resuspend:  
Add 250 μL Resuspension Buffer (R3) with RNase A to the cell pellet and resuspend the 
pellet until it is homogeneous. Mix well by pipetting up and down. 
3) Lyse: 
Add 250 μL Lysis Buffer (L7). Mix gently by inverting the capped tube until the mixture is 
homogeneous. Do not vortex, but carefully tip the tube.  Incubate the tube at room 
temperature for 5 minutes, do not exceed the time.  
4) Precipitate:   
Add 350 μL Precipitation Buffer (N4). Mix immediately by inverting the tube, or for large 
pellets, vigorously shaking the tube, until the mixture is homogeneous. Do not vortex, but 
gently tip the tubes. Centrifuge the lysate at >12,000 × g for 10 minutes.  
Bind:  
Load the supernatant into a spin column in a 2-mL wash tube. Centrifuge the column at 
12,000 × g for 1 minute. Discard the flow-through and place the column back into the wash 
tube. 
5) Wash and remove ethanol:  
Add 700 μL Wash Buffer (W9) with ethanol to the column. Centrifuge the column at 12,000 
× g for 1 minute. Discard the flow through and place the column into the wash tube. 
Centrifuge the column at 12,000 × g for 1 minute. Discard the wash tube with the flow-
through 
6) Elute:  
Place the Spin Column in a clean 1.5-mL recovery tube. Add 75 μL of preheated to 600C TE 
Buffer (TE) to the center of the column. Incubate the column for more than 1 minute at 
room temperature. 
7) Recover:  
Centrifuge the column at 12,000 × g for 2 minutes. The recovery tube contains the purified 
plasmid DNA. Discard the column. Store plasmid DNA at 4°C (short-term) or store the 
DNA in aliquots at −20°C (long-term). 
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Appendix 4 - Protocol for control cutting Thermo Scientific. 
 
1) 10X Buffer Tango 1.5 µL 
2) DNA plasmid 500 ng  
3) Nco1 0.7 µL*  
4) Add Nuclease-free water to total volume at 20 µL  
5) Mix gently and spin down for a few seconds 
6) Incubate at 37 °C for 2 hours* 
7) Run at 1% agarose gel dissolved in TAE buffer 
The digestion reaction may be scaled either up or down. 
*No detectable change in the specific fragmentation pattern is observed after a 80-fold over 
digestion with Nco1 (5 U/µg lambda DNA × 16 hours). 
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Appendix 5 - Protocol for NucleoBond® Xtra Midi/Maxi  
 
Plasmid DNA purification  
 
1. Place two columns in the rag containing the filter 
2. Place two 50 mL Falcon tubes below the columns 
3. Equilibrate with 25 mL EQU by adding EQU dropwise to the top of the filter 
4. The overnight cell cultures are centrifuged at 3000 rpm for 30 minutes at 4 °C 
5. The percipient are resuspented in 12 mL RES buffer 
6. Ad 12 mL LYS buffer to the sample, and shake the tube a little. 
7. Incubate for 5 minute 
8. To the samples ad 12 mL NEU buffer and shake the tube a bit 
9. Transfer the cell lyses to the column and wait till all the liquid have run through. 
10. Wash the column by slowly dropwise adding 50 mL and EQU buffer to the filter in the 
column 
11. Remove the filter 
12. Wash the column with 25 mL WASH 
13. 15 mL ELU per sample are heated on water bath at 50 °C. 
14. Replace the Flacon tubes below the columns 
15. Add the 15 mL heated ELU to the column. 
16. Discard the column 
17. Ad 10.5 isopropanol to the falcon tubes  
18. Incubate for 2 minutes  
19. Centrifuge the tubes at 15,000 x g for 30 min at 4 °C 
20. Remove the supernantant. 
21. Ad 5 mL freshly made 80% ethanol by washing the sides of the tube. 
22. Centrifuge the samples at 15,000 x g for 5 min  
23. The supernatant is removed and discharged 
24. The tubes are left without lid so the ethanol can evaporate 
25. The pellet are suspended in 400 µL water 
26. The DNA concentrations are determined at NanoDrop spec. at 260 nm 
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Appendix 6 - Protocol for protein concentration determination with 
Pierce® BCA protein assay kit 
 
Standard row 
1. The diluent for the protein measurement is RIPA buffer. The total volume of RIPA buffer 
needed for the measurement is the volume needed for the standard row and the volume 
needed for lyses of the cells. 
2. Volume for lysis is 200µL per well. We have 3 cell lines and 5 different samples of 
transfected cells. Then we multiply the volume needed for lysis with 4, so we are sure we 
have enough for the standard row as well. 
3. volume RIPA buffer = ((5 ∗ 3) ∗ 200µL) ∗ 4 = 12000 µL 
 
4. Mix 12 mL RIPA buffer as follow:  
a) To 12 mL RIPA buffer is added  
b) 12 µL DTT  
c) 24 µL protease  
DTT concentration is 1M so it needs to be diluted 100 times. 1µL DTT and 99 µL PBS 
buffer. 
5. Store it on ice. 
 
6. 1 ampule of albumin standard 2mg/mL is diluted with RIPA buffer according to table below  
 
nr Volume 
diluent 
RIPA 
Volume BSA Concentration  
µg/mL 
 
1 0 300 2000 
2 125 375 1500 
3 325 325 1000 
4 175 175 fra 2 750 
5 325 325 fra 3 500 
6 325 325 fra 5 250 
7 325 325 fra 6 125 
8 400 100 fra 7 25 
9 400 0 0 
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7. The volume Working reagent (WR) needed for the standard row and the protein 
measurement of the cells is calculated as followed:  
volume WR = (numbers of standard + numbers of samples) ∗ numbers of replicas ∗ volume of WR 
The total volume WR: 
volume WR = (9 + (5 ∗ 3)) ∗ (3) ∗ 200 µL = 19800 µL = 19,8 mL 
 
8. Working reagent: 
a) 25 mL reagent BSA A 
b) ½ mL reagent BSA B 
 
 
Cell lysis  
 
1. The medium is removed from the cells  
2. Rinse with 1.5 mL PBS 
3. Remove the PBS  
4. Add 200 µL RIPA buffer 
5. Leave it at ice for 15 min. 
6. With a pipet the cells are mixed with the RIPA by pipetting up and down a couple of times. 
(We did not register any slime, as expected, but a lot of foam) 
7. The mix is transferred to a Eppendorf tube and placed on ice 
8. The cells are further lysed by to shot sequences with a piston. Do not let the sample get hot. 
9. The tubes are centrifuged at 12,000g for 15 min. at 4 °C. 
10. The supernatant is transferred to a new Eppendorf tube. 
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Protein measurement 
1. To make 3 replicate of each sample 40 µL sample and 40µL RIPA buffer were mixed in 
Eppendorf tubes. 
2. The samples are set up in a 90 wells plate showed on the next page. 
3. The Plate is incubated for 30 minutes at 37 °C. 
4. The plate is placed on the table for about 10 minutes till it has room temperature.  
5. The absorbance is measured at 562 nm.  
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Appendix 7 - Bolt®Bis tris 4-12% (MES) SDS electroforece 
 
1. Make the running buffer 400 mL in each chamber plus additional to wash. NB. If two gels 
are running at the same time, there shall be the same buffer in both champers. Not MOPS in 
one and MES in the other.  
NuPAGE®4-12% Bis-Tris (MES) 
NuPAGE®4-12% Bis-Tris (MOPS) 
2. remove the cassette from the bag 
3. wash with deionized water 
4. Remove the cam 
5. Remove the tape in the bottom of the cassette 
6. Wash the wells with deionized water 
7. Fill the wells with running buffer. Be careful not to make bobbles 
8. Assemble the Bolt™ Mini Gel Tank: 
a. Place the electrophorese tank in the base. 
b. Put in the cassette clamp, with the anode place toward the center 
c. Fill the chambers with running buffer to just above the electrode line. 
d. Place the cassette with the wells facing toward you. 
e. Close the cassetteclamp 
f. Fill the wells with running buffer 
g. Load the samples, 10 µL samples and 4-5 µL markers 
h. Fill running buffer to the Fill line 
9. Running the electroforece 
a. Make sure the power is turned off. 
b. Is only one chamber benign used, make sure the cassette clamp is not in the others 
camper. 
c. Put on the lid 
d. Conect the elektrode cord. Red to +, and black to -. 
e. Turn on the power and run after the instructions for the minigel in question. 
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Geltype Voltage 
V 
Start 
current 
mA 
End current 
mA 
Time 
min 
NuPAGE®4-12% BIS-Tris (MES) 200 160 90 30 
NuPAGE®4-12% BIS-Tris 
(MOPS) 
200 140 50 42 
Bolt®Bis-Tris 4-12% (MES) 200 160 70 20 
Bolt®Bis-Tris 4-12% (MES) 200 160 50 42 
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Appendix 8 - Western blot Bolt™ Mini Blot Module 
 
• Make NuPAGE transfer buffer (1X) by mixing 50 mL NuPAGE transfer buffer, 200 mL 
Ethanol 100% and  750 mL MiliQ water. 
• Immerse filter pads in transfer buffer and roll the filter pads to make sure the air bobbles are 
out. 
• After the gel has run the gel is removed from the gel cassette by a gel knife 
• Remove gently the upper plate of the gel cassette and let the gel stay on the lower plate. Cut 
off the wells at the top of the gel. 
• Immerse filter paper in Transfer buffer with tweezers.  
• The PVDF membrane is immerse for 30 sec in ethanol 100%. Submerge in deionized water, 
and then immerse in transfer buffer for 5 min. 
• The transfer cartridge is assemble as followed. 
 
Bottom 
• 2 filter pads (blotting pads) 
• Filter paper 
• First gel 
• Transfer membrane 
• Filter paper 
• Blotting pads 
• Filter paper 
• Second gel 
• Transfer membrane 
• Filter paper 
• Filter pads. 
Top 
 
• Make sure to roll the sandwich in order to remove bobbles. 
• The transfer cartridge is assembled in hand and transferred to the chamber. 
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• In the chamber, with the sandwich, is added transfer buffer 
• In the outer chambers is added deionized water. 
• The transfer is run at 30V for an hour. 
After blotting 
• The blot is rinse shortly with water. 
• It is incubated in 5 mL blocking buffer (Nonfat dry milk from Cell Signaling Technology) 
• Wash the blot 2 x2 min in 20 mL Wash buffer (TBS 1X) 
• Dilute primary antibody in dilution buffer 2µL in 10 mL 
• Put the blot in a plastic bag with the primary antibody.  
• Incubate over night at 4 °C on a rocking table. 
• After incubation the blot is removed from the bag and washed 2 x 10 min in 20 mL wash 
buffer.  
• Dilute secondary antibody HRP- conjugate 1µL in 5 mL dilution buffer. 
• Incubate the blot for one hour. 
• After incubation the blot is washed 4 x 10 minutes in wash buffer. 
• Prepare a premix of 1.5 mL SuperSignal® WestDura Extended Duration Substrate. From 
Thermo Scientific. DO NOT EXPOSE TO LIGTH. 
• The premix is evenly distributed on the blot and incubated for 5 min, in darkness.  
• After incubation the blot is sealed in plastic wrap  
• The blot is exposed for time needed on G:Box using GeneSnap program both from 
SynGene. 
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Appendix 9 - Protocol for transfection 
 
1. Prepare DNA. Make 100µl 1.2µg/µl DNA in 150 mM NaCl pr well. 
2. Vortex the stock PEI25 for 1 min. Use it to generate a 2µM PEI25 in 150 mM NaCl. Vortex 
2µM PEI25 for 5 min.  
3. Mix DNA and PEI:  
a. 100µL 1,2µg/µL DNA in 150 mM NaCl, with  
b. 100µL 2µM PEI25 in 150 mM NaCl 
4. Vortex the mix 1 min, leave at RT for 1-2 hours, to let the DNA and PEI form precipitate 
5. Add the 200µL DNA/PEI25 to the cells in droplets around the surface of the well. 
6. Spin the plate at 1200rpm for 5 min. Note the time 
7. Leave cells in 37C + 5% CO2 incubator for 48 hours. (Some people change media after 4-16 
hours as the PEI might be bad company for the cells.)   
8. Change the medium after 24 hours 
9. After the 48 hours. Look at the cells. They should look healthy, be 60%-80% confluent, 
have a high percentage of transfected cells (only visible if DNA contain fluorescent protein 
selectable marker). 
10. Lyse the cells according to preferred protocol.  
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Appendix 10 – The sequence of vCDX2 
 
5’AATTCCTGGGCATCGCTTTCTGCGTCACTGTGCACATGCTAGGGAGAGTCCTGGTGGGAATGCCGCCGACCGGGGA
GAAGGCCACAGATCAGCCTCGGTGAAAACCAGGACGAAAGACAAATATCGAGTGGTGTACACGGACCACCAGCGGC
TGGAGCTGGAGAAGGAGTTTCACTACAGTCGCTACATCACCATCCGGAGGAAAGCCGAGCTAGCCGCCACGCTGGG
GCTCTCTGAGAGGCAGGTTAAAATCTGGTTTCAGAACCGCAGAGCAAAGGAGAGGAAAATCAACAAGAAGAAGTTG
CAGCAGCAACAGCAGCAGCAGCCACCACAGCCGCCTCCGCCGCCACCACAGCCTCCCCAGCCTCAGCCAGGTCCTCTG
AGAAGTGTCCCAGAGCCCTTGAGTCCGGTGTCTTCCCTGCAAGCCTCAGTGTCTGGCTCTGTCCCTGGGGTTCTGGGG
CCAACTGGGGGGGTGCTAAACCCCACCGTCACCCAG 3’ 
 
 
